Another study conducted by Luo et al. [137] verified that a high score of pre-treatment serum ALB–BIL grade combined with pre-treatment serum AST/PLT ratio was independently associated with worse OS and RFS in HCC patients receiving curative surgical resection. Here, ALB is linked to hepatocellular carcinoma.